

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | omega-hydroxylase P450 pathway (GO:0097267) | 9.77818595 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.22093865 |
| 3 | regulation of protein activation cascade (GO:2000257) | 9.00782815 |
| 4 | regulation of complement activation (GO:0030449) | 8.48646736 |
| 5 | regulation of fibrinolysis (GO:0051917) | 7.62595271 |
| 6 | negative regulation of fibrinolysis (GO:0051918) | 7.46792557 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 7.37710444 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.37710444 |
| 9 | cellular glucuronidation (GO:0052695) | 7.20087289 |
| 10 | urea metabolic process (GO:0019627) | 6.86903607 |
| 11 | uronic acid metabolic process (GO:0006063) | 6.81023536 |
| 12 | glucuronate metabolic process (GO:0019585) | 6.81023536 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 6.76224104 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.76224104 |
| 15 | glyoxylate metabolic process (GO:0046487) | 6.69371910 |
| 16 | drug metabolic process (GO:0017144) | 6.33212742 |
| 17 | nitrogen cycle metabolic process (GO:0071941) | 6.28407777 |
| 18 | blood coagulation, intrinsic pathway (GO:0007597) | 6.16248507 |
| 19 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 6.10876142 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.96080685 |
| 21 | protein carboxylation (GO:0018214) | 5.96080685 |
| 22 | oxidative demethylation (GO:0070989) | 5.83109651 |
| 23 | fibrinolysis (GO:0042730) | 5.82231413 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 5.81105379 |
| 25 | protein activation cascade (GO:0072376) | 5.79258137 |
| 26 | bile acid biosynthetic process (GO:0006699) | 5.74456279 |
| 27 | opsonization (GO:0008228) | 5.72105371 |
| 28 | urea cycle (GO:0000050) | 5.56704063 |
| 29 | complement activation (GO:0006956) | 5.56463839 |
| 30 | negative regulation of protein activation cascade (GO:2000258) | 5.48644611 |
| 31 | regulation of triglyceride catabolic process (GO:0010896) | 5.46037800 |
| 32 | regulation of humoral immune response (GO:0002920) | 5.40619337 |
| 33 | complement activation, classical pathway (GO:0006958) | 5.29720303 |
| 34 | bile acid metabolic process (GO:0008206) | 5.26975492 |
| 35 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.26355462 |
| 36 | cytolysis (GO:0019835) | 5.17563100 |
| 37 | bile acid and bile salt transport (GO:0015721) | 5.09938025 |
| 38 | acute-phase response (GO:0006953) | 5.01295076 |
| 39 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.91910492 |
| 40 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.91910492 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 4.89836775 |
| 42 | negative regulation of blood coagulation (GO:0030195) | 4.70917200 |
| 43 | negative regulation of hemostasis (GO:1900047) | 4.70917200 |
| 44 | ethanol oxidation (GO:0006069) | 4.65866152 |
| 45 | flavonoid metabolic process (GO:0009812) | 4.51844696 |
| 46 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.51474501 |
| 47 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.51474501 |
| 48 | imidazole-containing compound metabolic process (GO:0052803) | 4.50577238 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.50168207 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.50168207 |
| 51 | indole-containing compound catabolic process (GO:0042436) | 4.41900877 |
| 52 | indolalkylamine catabolic process (GO:0046218) | 4.41900877 |
| 53 | tryptophan catabolic process (GO:0006569) | 4.41900877 |
| 54 | phenylpropanoid metabolic process (GO:0009698) | 4.39021701 |
| 55 | tyrosine metabolic process (GO:0006570) | 4.37044962 |
| 56 | regulation of plasminogen activation (GO:0010755) | 4.37026757 |
| 57 | hormone catabolic process (GO:0042447) | 4.30187887 |
| 58 | negative regulation of coagulation (GO:0050819) | 4.26735657 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.25637079 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.25637079 |
| 61 | negative regulation of wound healing (GO:0061045) | 4.25360281 |
| 62 | glycine metabolic process (GO:0006544) | 4.25295977 |
| 63 | S-adenosylmethionine metabolic process (GO:0046500) | 4.15135216 |
| 64 | negative regulation of complement activation (GO:0045916) | 4.01343776 |
| 65 | positive regulation of blood coagulation (GO:0030194) | 3.94662362 |
| 66 | positive regulation of hemostasis (GO:1900048) | 3.94662362 |
| 67 | amino-acid betaine metabolic process (GO:0006577) | 3.94287592 |
| 68 | polyketide metabolic process (GO:0030638) | 3.77118276 |
| 69 | doxorubicin metabolic process (GO:0044598) | 3.77118276 |
| 70 | daunorubicin metabolic process (GO:0044597) | 3.77118276 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 3.76883094 |
| 72 | protein-lipid complex remodeling (GO:0034368) | 3.76883094 |
| 73 | macromolecular complex remodeling (GO:0034367) | 3.76883094 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.76307377 |
| 75 | arginine metabolic process (GO:0006525) | 3.75152256 |
| 76 | glutamate metabolic process (GO:0006536) | 3.72083803 |
| 77 | regulation of acute inflammatory response (GO:0002673) | 3.71127157 |
| 78 | ethanol metabolic process (GO:0006067) | 3.71121818 |
| 79 | sodium-independent organic anion transport (GO:0043252) | 3.70354587 |
| 80 | arginine catabolic process (GO:0006527) | 3.68724288 |
| 81 | positive regulation of coagulation (GO:0050820) | 3.66158276 |
| 82 | tryptophan metabolic process (GO:0006568) | 3.65768024 |
| 83 | acute inflammatory response (GO:0002526) | 3.63598292 |
| 84 | alkaloid metabolic process (GO:0009820) | 3.57336156 |
| 85 | alpha-amino acid catabolic process (GO:1901606) | 3.53177927 |
| 86 | xenobiotic metabolic process (GO:0006805) | 3.52515520 |
| 87 | regulation of apoptotic cell clearance (GO:2000425) | 3.42269397 |
| 88 | phospholipid efflux (GO:0033700) | 3.41293196 |
| 89 | xenobiotic catabolic process (GO:0042178) | 3.37883097 |
| 90 | heme transport (GO:0015886) | 3.37120302 |
| 91 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.34967031 |
| 92 | serine family amino acid metabolic process (GO:0009069) | 3.34641535 |
| 93 | aminoglycoside antibiotic metabolic process (GO:0030647) | 3.34350756 |
| 94 | cholesterol efflux (GO:0033344) | 3.33869161 |
| 95 | high-density lipoprotein particle remodeling (GO:0034375) | 3.33745340 |
| 96 | response to mercury ion (GO:0046689) | 3.31161072 |
| 97 | phospholipid homeostasis (GO:0055091) | 3.29993119 |
| 98 | exogenous drug catabolic process (GO:0042738) | 11.2890924 |
| 99 | complement activation, alternative pathway (GO:0006957) | 10.6208529 |
| 100 | drug catabolic process (GO:0042737) | 10.2294136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.76726940 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.58770618 |
| 3 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.03570768 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.17690388 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.94069087 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.72884591 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.27033070 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.94955937 |
| 9 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.55170910 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.48737920 |
| 11 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.39820778 |
| 12 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.36928039 |
| 13 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.23751677 |
| 14 | HTT_18923047_ChIP-ChIP_STHdh_Human | 2.14703216 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.00342027 |
| 16 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.89075220 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.83324242 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75404112 |
| 19 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.42445356 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.40659903 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.38841943 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29695113 |
| 23 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.29665834 |
| 24 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.26533190 |
| 25 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.24044516 |
| 26 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.20304052 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.16968365 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.16917819 |
| 29 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.15899734 |
| 30 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 1.10406382 |
| 31 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.07902528 |
| 32 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.07562245 |
| 33 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 1.07394218 |
| 34 | NFYA_21822215_ChIP-Seq_K562_Human | 1.06661697 |
| 35 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.04988351 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.04153554 |
| 37 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.03392828 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98876772 |
| 39 | CBP_21632823_ChIP-Seq_H3396_Human | 0.96879487 |
| 40 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.96773358 |
| 41 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.94440329 |
| 42 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.93210906 |
| 43 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93150815 |
| 44 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.91119387 |
| 45 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91064369 |
| 46 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.90098117 |
| 47 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.90098117 |
| 48 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.90050535 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.87229358 |
| 50 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.86800846 |
| 51 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.86800846 |
| 52 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.86661696 |
| 53 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.85960282 |
| 54 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.85356545 |
| 55 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.85125584 |
| 56 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.84973052 |
| 57 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.84970303 |
| 58 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.84518564 |
| 59 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.84161538 |
| 60 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.82856485 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82379804 |
| 62 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.81984689 |
| 63 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.81743833 |
| 64 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.81731821 |
| 65 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80630925 |
| 66 | NFYB_21822215_ChIP-Seq_K562_Human | 0.78793975 |
| 67 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.78562970 |
| 68 | AR_20517297_ChIP-Seq_VCAP_Human | 0.78474532 |
| 69 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78348172 |
| 70 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.77443232 |
| 71 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.76864008 |
| 72 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.76468843 |
| 73 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.75932923 |
| 74 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.75742460 |
| 75 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.75717994 |
| 76 | STAT3_23295773_ChIP-Seq_U87_Human | 0.75668153 |
| 77 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.75543055 |
| 78 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.73981230 |
| 79 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.72759265 |
| 80 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.71426066 |
| 81 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71387284 |
| 82 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.71131519 |
| 83 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.70974236 |
| 84 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.70954674 |
| 85 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 0.70557177 |
| 86 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70029780 |
| 87 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.69420075 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.68966845 |
| 89 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.68913186 |
| 90 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.68901208 |
| 91 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68247962 |
| 92 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.67320108 |
| 93 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.66579331 |
| 94 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.66145741 |
| 95 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.65746495 |
| 96 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.65746495 |
| 97 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.65663480 |
| 98 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.65425677 |
| 99 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.64732463 |
| 100 | GATA2_19941826_ChIP-Seq_K562_Human | 0.64541269 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.58315801 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.29200166 |
| 3 | MP0005365_abnormal_bile_salt | 5.81908601 |
| 4 | MP0003195_calcinosis | 5.47257003 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 5.37491380 |
| 6 | MP0005360_urolithiasis | 5.29332301 |
| 7 | MP0003252_abnormal_bile_duct | 5.07713183 |
| 8 | MP0008875_abnormal_xenobiotic_pharmacok | 5.06627129 |
| 9 | MP0003868_abnormal_feces_composition | 3.12499086 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.88221653 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.55728205 |
| 12 | MP0009697_abnormal_copulation | 2.39992795 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.31425010 |
| 14 | MP0005332_abnormal_amino_acid | 2.27798289 |
| 15 | MP0010368_abnormal_lymphatic_system | 2.19266154 |
| 16 | MP0000609_abnormal_liver_physiology | 1.80832628 |
| 17 | MP0005464_abnormal_platelet_physiology | 1.71637289 |
| 18 | MP0009840_abnormal_foam_cell | 1.65326529 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.64068056 |
| 20 | MP0002118_abnormal_lipid_homeostasis | 1.61194682 |
| 21 | MP0002876_abnormal_thyroid_physiology | 1.56956222 |
| 22 | MP0002132_abnormal_respiratory_system | 1.47239070 |
| 23 | MP0001661_extended_life_span | 1.40008636 |
| 24 | MP0005670_abnormal_white_adipose | 1.37329555 |
| 25 | MP0001764_abnormal_homeostasis | 1.32043038 |
| 26 | MP0005319_abnormal_enzyme/_coenzyme | 1.09999450 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.04643936 |
| 28 | MP0000598_abnormal_liver_morphology | 1.04284191 |
| 29 | MP0009764_decreased_sensitivity_to | 1.03393130 |
| 30 | MP0005408_hypopigmentation | 1.01865086 |
| 31 | MP0003656_abnormal_erythrocyte_physiolo | 1.00810954 |
| 32 | MP0004019_abnormal_vitamin_homeostasis | 0.99799835 |
| 33 | MP0009763_increased_sensitivity_to | 0.97106217 |
| 34 | MP0005187_abnormal_penis_morphology | 0.95380695 |
| 35 | MP0009053_abnormal_anal_canal | 0.93139437 |
| 36 | MP0002971_abnormal_brown_adipose | 0.88712048 |
| 37 | MP0009642_abnormal_blood_homeostasis | 0.85824470 |
| 38 | MP0009643_abnormal_urine_homeostasis | 0.85321618 |
| 39 | MP0008469_abnormal_protein_level | 0.83200383 |
| 40 | MP0001915_intracranial_hemorrhage | 0.79162432 |
| 41 | MP0005395_other_phenotype | 0.79032400 |
| 42 | MP0005376_homeostasis/metabolism_phenot | 0.76448129 |
| 43 | MP0002168_other_aberrant_phenotype | 0.75776060 |
| 44 | MP0003690_abnormal_glial_cell | 0.69844045 |
| 45 | MP0002282_abnormal_trachea_morphology | 0.65781206 |
| 46 | MP0005636_abnormal_mineral_homeostasis | 0.65187292 |
| 47 | MP0005023_abnormal_wound_healing | 0.64990632 |
| 48 | MP0005451_abnormal_body_composition | 0.64981103 |
| 49 | MP0009785_altered_susceptibility_to | 0.61419728 |
| 50 | MP0003186_abnormal_redox_activity | 0.61054150 |
| 51 | MP0002078_abnormal_glucose_homeostasis | 0.59709288 |
| 52 | MP0008872_abnormal_physiological_respon | 0.58823258 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 0.58700920 |
| 54 | MP0000604_amyloidosis | 0.58518641 |
| 55 | MP0003879_abnormal_hair_cell | 0.58450840 |
| 56 | MP0003638_abnormal_response/metabolism_ | 0.58266917 |
| 57 | MP0004130_abnormal_muscle_cell | 0.57078939 |
| 58 | MP0005535_abnormal_body_temperature | 0.56893803 |
| 59 | MP0003011_delayed_dark_adaptation | 0.56543986 |
| 60 | MP0005166_decreased_susceptibility_to | 0.56371980 |
| 61 | MP0005647_abnormal_sex_gland | 0.54870008 |
| 62 | MP0005397_hematopoietic_system_phenotyp | 0.54801250 |
| 63 | MP0001545_abnormal_hematopoietic_system | 0.54801250 |
| 64 | MP0005334_abnormal_fat_pad | 0.54624724 |
| 65 | MP0005164_abnormal_response_to | 0.53656624 |
| 66 | MP0005266_abnormal_metabolism | 0.53297487 |
| 67 | MP0008874_decreased_physiological_sensi | 0.53268072 |
| 68 | MP0005410_abnormal_fertilization | 0.52264241 |
| 69 | MP0009765_abnormal_xenobiotic_induced | 0.50061071 |
| 70 | MP0008004_abnormal_stomach_pH | 0.46538585 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.46158146 |
| 72 | MP0002332_abnormal_exercise_endurance | 0.43477690 |
| 73 | MP0005220_abnormal_exocrine_pancreas | 0.43448050 |
| 74 | MP0000249_abnormal_blood_vessel | 0.42540897 |
| 75 | MP0002136_abnormal_kidney_physiology | 0.41600974 |
| 76 | MP0000858_altered_metastatic_potential | 0.40478264 |
| 77 | MP0004272_abnormal_basement_membrane | 0.40445419 |
| 78 | MP0004883_abnormal_blood_vessel | 0.39696226 |
| 79 | MP0009115_abnormal_fat_cell | 0.39004929 |
| 80 | MP0005448_abnormal_energy_balance | 0.38349411 |
| 81 | MP0001845_abnormal_inflammatory_respons | 0.38085452 |
| 82 | MP0001756_abnormal_urination | 0.37254815 |
| 83 | MP0002128_abnormal_blood_circulation | 0.34756278 |
| 84 | MP0005084_abnormal_gallbladder_morpholo | 0.32268412 |
| 85 | MP0003633_abnormal_nervous_system | 0.31832300 |
| 86 | MP0002249_abnormal_larynx_morphology | 0.31499044 |
| 87 | MP0003632_abnormal_nervous_system | 0.31312457 |
| 88 | MP0001851_eye_inflammation | 0.31015514 |
| 89 | MP0008775_abnormal_heart_ventricle | 0.30511833 |
| 90 | MP0005083_abnormal_biliary_tract | 0.29944051 |
| 91 | MP0005666_abnormal_adipose_tissue | 0.29640621 |
| 92 | MP0010155_abnormal_intestine_physiology | 0.28397989 |
| 93 | MP0002419_abnormal_innate_immunity | 0.28050117 |
| 94 | MP0003953_abnormal_hormone_level | 0.27510772 |
| 95 | MP0003566_abnormal_cell_adhesion | 0.27392625 |
| 96 | MP0003959_abnormal_lean_body | 0.26775732 |
| 97 | MP0003631_nervous_system_phenotype | 0.26644971 |
| 98 | MP0000920_abnormal_myelination | 0.24898046 |
| 99 | MP0000639_abnormal_adrenal_gland | 0.24302948 |
| 100 | MP0003075_altered_response_to | 0.23916740 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Conjugated hyperbilirubinemia (HP:0002908) | 9.00572027 |
| 2 | Abnormality of complement system (HP:0005339) | 8.95131253 |
| 3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 8.85634113 |
| 4 | Deep venous thrombosis (HP:0002625) | 8.60497222 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 8.25023634 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.13847257 |
| 7 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 6.76927794 |
| 8 | Glomerulonephritis (HP:0000099) | 6.31976359 |
| 9 | Intrahepatic cholestasis (HP:0001406) | 6.16705504 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 6.15557005 |
| 11 | Spontaneous abortion (HP:0005268) | 5.93841338 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 5.92411745 |
| 13 | Joint hemorrhage (HP:0005261) | 5.92342012 |
| 14 | Hyperlipoproteinemia (HP:0010980) | 5.43916852 |
| 15 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.09739607 |
| 16 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.87464306 |
| 17 | Abnormality of the intrinsic pathway (HP:0010989) | 4.45488032 |
| 18 | Xanthomatosis (HP:0000991) | 4.36528179 |
| 19 | Nephritis (HP:0000123) | 4.35000202 |
| 20 | Gingival bleeding (HP:0000225) | 4.32422001 |
| 21 | Hypolipoproteinemia (HP:0010981) | 3.95456977 |
| 22 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.68218104 |
| 23 | Fat malabsorption (HP:0002630) | 3.60612416 |
| 24 | Generalized aminoaciduria (HP:0002909) | 3.35414916 |
| 25 | Menorrhagia (HP:0000132) | 3.17658305 |
| 26 | Mitral stenosis (HP:0001718) | 3.14566282 |
| 27 | Purpura (HP:0000979) | 3.14208301 |
| 28 | Thrombophlebitis (HP:0004418) | 3.00002035 |
| 29 | Hypoalphalipoproteinemia (HP:0003233) | 2.98250444 |
| 30 | Hyperbilirubinemia (HP:0002904) | 2.93683618 |
| 31 | Hepatocellular carcinoma (HP:0001402) | 2.90594295 |
| 32 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.83750317 |
| 33 | Abnormality of methionine metabolism (HP:0010901) | 2.82963492 |
| 34 | Joint swelling (HP:0001386) | 2.81879017 |
| 35 | Hyperammonemia (HP:0001987) | 2.74996655 |
| 36 | Epistaxis (HP:0000421) | 2.73964975 |
| 37 | Vascular calcification (HP:0004934) | 2.70659133 |
| 38 | Rickets (HP:0002748) | 2.58298445 |
| 39 | Hypercholesterolemia (HP:0003124) | 2.52856038 |
| 40 | Cholelithiasis (HP:0001081) | 2.51730782 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 2.48745800 |
| 42 | Increased mean platelet volume (HP:0011877) | 2.47034635 |
| 43 | Abnormal gallbladder morphology (HP:0012437) | 2.45994734 |
| 44 | Hemorrhage of the eye (HP:0011885) | 2.39527756 |
| 45 | Cardiovascular calcification (HP:0011915) | 2.37587588 |
| 46 | Hyperglycinemia (HP:0002154) | 2.36963657 |
| 47 | Reduced antithrombin III activity (HP:0001976) | 2.29746553 |
| 48 | Pulmonary embolism (HP:0002204) | 2.29117901 |
| 49 | Osteomalacia (HP:0002749) | 2.28960575 |
| 50 | Steatorrhea (HP:0002570) | 2.27515556 |
| 51 | Abnormal platelet volume (HP:0011876) | 2.26429457 |
| 52 | Fair hair (HP:0002286) | 2.17166361 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.14783185 |
| 54 | Epidermoid cyst (HP:0200040) | 2.12265004 |
| 55 | Elevated alkaline phosphatase (HP:0003155) | 2.02278372 |
| 56 | Abnormality of serum amino acid levels (HP:0003112) | 2.02268802 |
| 57 | Myocardial infarction (HP:0001658) | 2.01861920 |
| 58 | Hypophosphatemic rickets (HP:0004912) | 2.01099258 |
| 59 | Complement deficiency (HP:0004431) | 11.2396732 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 1.97117634 |
| 61 | Cholecystitis (HP:0001082) | 1.97117634 |
| 62 | Increased serum ferritin (HP:0003281) | 1.95240258 |
| 63 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.94399649 |
| 64 | Abnormality of glycine metabolism (HP:0010895) | 1.94399649 |
| 65 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.93752308 |
| 66 | Amyloidosis (HP:0011034) | 1.89762012 |
| 67 | Abnormality of iron homeostasis (HP:0011031) | 1.89694884 |
| 68 | Abnormal biliary tract physiology (HP:0012439) | 1.89393562 |
| 69 | Bile duct proliferation (HP:0001408) | 1.89393562 |
| 70 | Prolonged bleeding time (HP:0003010) | 1.87497421 |
| 71 | Poikilocytosis (HP:0004447) | 1.85914878 |
| 72 | Abnormal delivery (HP:0001787) | 1.83565597 |
| 73 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.83243795 |
| 74 | Abnormal platelet function (HP:0011869) | 1.81721294 |
| 75 | Impaired platelet aggregation (HP:0003540) | 1.81721294 |
| 76 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.79791876 |
| 77 | Delayed CNS myelination (HP:0002188) | 1.78619535 |
| 78 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78607942 |
| 79 | Glycosuria (HP:0003076) | 1.76032978 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 1.76032978 |
| 81 | Gangrene (HP:0100758) | 1.69099285 |
| 82 | Cerebral palsy (HP:0100021) | 1.68572258 |
| 83 | Arthropathy (HP:0003040) | 1.68216913 |
| 84 | Hyperglycinuria (HP:0003108) | 1.66916675 |
| 85 | Abnormality of the gallbladder (HP:0005264) | 1.66341829 |
| 86 | Abnormality of vitamin metabolism (HP:0100508) | 1.63620075 |
| 87 | Neonatal hypoglycemia (HP:0001998) | 1.63381153 |
| 88 | Hyperphosphaturia (HP:0003109) | 1.60931881 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 1.59653091 |
| 90 | Metabolic acidosis (HP:0001942) | 1.59555806 |
| 91 | Generalized hypopigmentation of hair (HP:0011358) | 1.57860176 |
| 92 | Proximal tubulopathy (HP:0000114) | 1.57361965 |
| 93 | Acanthocytosis (HP:0001927) | 1.54804633 |
| 94 | Irritability (HP:0000737) | 1.53946076 |
| 95 | Ketosis (HP:0001946) | 1.53049223 |
| 96 | Enlarged kidneys (HP:0000105) | 1.51513333 |
| 97 | Anorexia (HP:0002039) | 1.50402653 |
| 98 | Pancreatitis (HP:0001733) | 1.48444706 |
| 99 | Hypoglycemic coma (HP:0001325) | 1.45392999 |
| 100 | Bifid scrotum (HP:0000048) | 1.45138829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 5.29957653 |
| 2 | PINK1 | 3.89051987 |
| 3 | TRIM28 | 3.39005004 |
| 4 | MYLK | 2.66451182 |
| 5 | SIK3 | 2.61779985 |
| 6 | EPHA3 | 2.30530626 |
| 7 | MARK3 | 2.28466901 |
| 8 | TAOK3 | 2.09646293 |
| 9 | FGFR4 | 2.09193251 |
| 10 | BCR | 1.92634871 |
| 11 | MAP3K3 | 1.90976366 |
| 12 | MST4 | 1.73625593 |
| 13 | ERN1 | 1.72794536 |
| 14 | NLK | 1.66772859 |
| 15 | ZAP70 | 1.64645820 |
| 16 | PRKACG | 1.61838161 |
| 17 | MAP3K2 | 1.53205404 |
| 18 | STK38 | 1.50548224 |
| 19 | MAP3K1 | 1.46731365 |
| 20 | FRK | 1.45122243 |
| 21 | FGFR3 | 1.42396233 |
| 22 | TYK2 | 1.41687428 |
| 23 | JAK1 | 1.38097859 |
| 24 | BLK | 1.34518201 |
| 25 | PRKAA2 | 1.22921701 |
| 26 | KSR1 | 1.22824189 |
| 27 | EPHB1 | 1.22290308 |
| 28 | KSR2 | 1.19279928 |
| 29 | MAPK11 | 1.17050768 |
| 30 | RET | 1.16606177 |
| 31 | PIK3CA | 1.15074286 |
| 32 | BMPR1B | 1.14120777 |
| 33 | MAP3K5 | 1.12812371 |
| 34 | TNK2 | 1.11995451 |
| 35 | RIPK1 | 1.10502724 |
| 36 | IGF1R | 1.08518221 |
| 37 | MAP3K13 | 1.07510181 |
| 38 | ACVR1B | 1.04703858 |
| 39 | GRK6 | 0.98923374 |
| 40 | TLK1 | 0.96077065 |
| 41 | FER | 0.95001561 |
| 42 | CAMKK2 | 0.94799161 |
| 43 | CSNK1G1 | 0.93269117 |
| 44 | BTK | 0.93103838 |
| 45 | JAK2 | 0.92653890 |
| 46 | PRPF4B | 0.86762917 |
| 47 | TIE1 | 0.86532816 |
| 48 | PDPK1 | 0.85904099 |
| 49 | NTRK3 | 0.83142143 |
| 50 | TEC | 0.82846260 |
| 51 | PDK1 | 0.81395684 |
| 52 | BMX | 0.78130815 |
| 53 | PRKG1 | 0.75550008 |
| 54 | CSNK1A1L | 0.73702138 |
| 55 | SIK1 | 0.73096933 |
| 56 | MAP2K1 | 0.72602067 |
| 57 | CSNK1G3 | 0.71080860 |
| 58 | DAPK2 | 0.70875362 |
| 59 | PTK2B | 0.70441003 |
| 60 | MAP2K3 | 0.70386099 |
| 61 | TAOK2 | 0.67763856 |
| 62 | STK38L | 0.67149727 |
| 63 | PRKCG | 0.64998125 |
| 64 | PRKCQ | 0.64638819 |
| 65 | ARAF | 0.64116390 |
| 66 | STK24 | 0.63155203 |
| 67 | CSNK1G2 | 0.63147259 |
| 68 | CSF1R | 0.62973164 |
| 69 | SYK | 0.62707035 |
| 70 | MAP3K12 | 0.61900415 |
| 71 | GRK1 | 0.59878869 |
| 72 | IRAK1 | 0.59795696 |
| 73 | PRKAA1 | 0.59691358 |
| 74 | MAP2K4 | 0.58926357 |
| 75 | MST1R | 0.58820318 |
| 76 | PAK3 | 0.58761599 |
| 77 | BRSK2 | 0.56613186 |
| 78 | RAF1 | 0.56123381 |
| 79 | ERBB4 | 0.55934270 |
| 80 | TBK1 | 0.53996673 |
| 81 | MET | 0.53124349 |
| 82 | TXK | 0.51556869 |
| 83 | STK3 | 0.51007355 |
| 84 | SGK2 | 0.50944700 |
| 85 | AKT3 | 0.50840662 |
| 86 | KDR | 0.50371256 |
| 87 | CSNK1D | 0.49930771 |
| 88 | SGK223 | 0.49491958 |
| 89 | SGK494 | 0.49491958 |
| 90 | PRKCB | 0.47167535 |
| 91 | LATS1 | 0.46684181 |
| 92 | RPS6KA5 | 0.46189379 |
| 93 | SGK3 | 0.43904994 |
| 94 | CSNK1E | 0.43380951 |
| 95 | NEK9 | 0.43195458 |
| 96 | PRKACA | 0.42713779 |
| 97 | PRKACB | 0.42249675 |
| 98 | HCK | 0.41694017 |
| 99 | EIF2AK3 | 0.39954797 |
| 100 | EIF2AK1 | 0.37575371 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.50587375 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.09972657 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.90112032 |
| 4 | Caffeine metabolism_Homo sapiens_hsa00232 | 3.75381085 |
| 5 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.73982562 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.60101523 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.33127228 |
| 8 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.06443796 |
| 9 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 3.05487429 |
| 10 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.93793645 |
| 11 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.88597989 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.81321832 |
| 13 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.35642112 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.19448180 |
| 15 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.15133889 |
| 16 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.14176874 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10577767 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.05198844 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.01097857 |
| 20 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.95695103 |
| 21 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.87384058 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.87098831 |
| 23 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.84347148 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.78491963 |
| 25 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.74981769 |
| 26 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.72985330 |
| 27 | Histidine metabolism_Homo sapiens_hsa00340 | 1.67591624 |
| 28 | Prion diseases_Homo sapiens_hsa05020 | 1.58770972 |
| 29 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.43821128 |
| 30 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39873749 |
| 31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.37225753 |
| 32 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.25880958 |
| 33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23895975 |
| 34 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.23559066 |
| 35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.23252418 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.22334638 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.13854457 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.07882072 |
| 39 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07316056 |
| 40 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.97105690 |
| 41 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95722182 |
| 42 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.93137792 |
| 43 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.89530597 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.82560391 |
| 45 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.73850057 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70436797 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66638738 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.63914820 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.62617843 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62211516 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.59546984 |
| 52 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.57249840 |
| 53 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55781930 |
| 54 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.54962304 |
| 55 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.52341944 |
| 56 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.47459970 |
| 57 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45961490 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.45553930 |
| 59 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36942591 |
| 60 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.36391527 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.34417508 |
| 62 | Insulin resistance_Homo sapiens_hsa04931 | 0.26777140 |
| 63 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.24623060 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.22184370 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.21982090 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19473815 |
| 67 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.17858916 |
| 68 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.11990600 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.11395243 |
| 70 | Amoebiasis_Homo sapiens_hsa05146 | 0.10258833 |
| 71 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.08523601 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.07950122 |
| 73 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.07320952 |
| 74 | Sulfur relay system_Homo sapiens_hsa04122 | 0.05086201 |
| 75 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.03151163 |
| 76 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.01498262 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.00236107 |
| 78 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.00086077 |
| 79 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | -0.2268225 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | -0.2263709 |
| 81 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2205560 |
| 82 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.2105456 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.1973271 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1714077 |
| 85 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1704073 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1652727 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.1631475 |
| 88 | Phagosome_Homo sapiens_hsa04145 | -0.1621171 |
| 89 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1494411 |
| 90 | Other glycan degradation_Homo sapiens_hsa00511 | -0.1475548 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1472582 |
| 92 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1345955 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1178497 |
| 94 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1020465 |
| 95 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.0665382 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0585330 |
| 97 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | -0.0475485 |
| 98 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | -0.0230688 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | -0.0082888 |
| 100 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0047254 |

